<http://identifiers.org/pubmed/16125839> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.biopax.org/release/biopax-level3.owl#PublicationXref> .
<http://identifiers.org/pubmed/16125839> <http://www.biopax.org/release/biopax-level3.owl#db> "PubMed"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://identifiers.org/pubmed/16125839> <http://www.biopax.org/release/biopax-level3.owl#id> "16125839"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://identifiers.org/pubmed/16125839> <http://www.biopax.org/release/biopax-level3.owl#title> "Synthetic progestins used in HRT have different glucocorticoid agonist properties."^^<http://www.w3.org/2001/XMLSchema#string> .
<http://identifiers.org/pubmed/16125839> <http://www.biopax.org/release/biopax-level3.owl#url> "http://www.phosphosite.org/curatedInfoAction.do?record=6992"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://identifiers.org/pubmed/16125839> <http://www.biopax.org/release/biopax-level3.owl#year> "2005"^^<http://www.w3.org/2001/XMLSchema#int> .
<http://www.phosphosite.org/phosphosite.owl#evidence_6992_EvidenceCodeVocabulary_0421> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/16125839> .
<http://www.phosphosite.org/phosphosite.owl#evidence_6992_EvidenceCodeVocabulary_0113> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/16125839> .